Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation | Zendy

George Ntaios | Zendy; Vasileios Papavasileiou | Zendy; Konstantinos Makaritsis | Zendy; Konstantinos Vemmos | Zendy; Patrik Michel | Zendy; Gregory Y.H. Lip | Zendy

Open Access

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

Author(s) -

George Ntaios,

Vasileios Papavasileiou,

Konstantinos Makaritsis,

Konstantinos Vemmos,

Patrik Michel,

Gregory Y.H. Lip

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.117.017549

Subject(s) - medicine , atrial fibrillation , vitamin k antagonist , stroke (engine) , antagonist , vitamin k , cardiology , warfarin , receptor , mechanical engineering , engineering

Evidence from the real-world setting complements evidence coming from randomized controlled trials. We aimed to summarize all available evidence from high-quality real-world observational studies about efficacy and safety of nonvitamin-K oral anticoagulants compared with vitamin-K antagonists in patients with atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research